Ignite Creation Date:
2025-12-25 @ 1:10 AM
Ignite Modification Date:
2026-01-02 @ 3:28 AM
Study NCT ID:
NCT00427193
Status:
COMPLETED
Last Update Posted:
2022-03-16
First Post:
2007-01-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CALERIE: Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D004198', 'term': 'Disease Susceptibility'}, {'id': 'D007333', 'term': 'Insulin Resistance'}], 'ancestors': [{'id': 'D020969', 'term': 'Disease Attributes'}, {'id': 'D010335', 'term': 'Pathologic Processes'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}, {'id': 'D006946', 'term': 'Hyperinsulinism'}, {'id': 'D044882', 'term': 'Glucose Metabolism Disorders'}, {'id': 'D008659', 'term': 'Metabolic Diseases'}, {'id': 'D009750', 'term': 'Nutritional and Metabolic Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D031204', 'term': 'Caloric Restriction'}], 'ancestors': [{'id': 'D004035', 'term': 'Diet Therapy'}, {'id': 'D044623', 'term': 'Nutrition Therapy'}, {'id': 'D013812', 'term': 'Therapeutics'}, {'id': 'D002149', 'term': 'Energy Intake'}, {'id': 'D004032', 'term': 'Diet'}, {'id': 'D009747', 'term': 'Nutritional Physiological Phenomena'}, {'id': 'D000066888', 'term': 'Diet, Food, and Nutrition'}, {'id': 'D010829', 'term': 'Physiological Phenomena'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'william.kraus@duke.edu', 'phone': '919-681-6733', 'title': 'William E. Kraus, Director of Clinical Research, Duke Center for Living', 'organization': 'Duke University Medical Center'}, 'certainAgreement': {'piSponsorEmployee': True, 'restrictiveAgreement': False}, 'limitationsAndCaveats': {'description': '1. The Caloric Restriction (CR) group fell short of achieving the 25% CR goal specified in the protocol.\n2. The completion rates differed between groups.'}}, 'adverseEventsModule': {'timeFrame': '0 to 24 months', 'eventGroups': [{'id': 'EG000', 'title': 'Caloric Restriction (CR)', 'description': '25% caloric restriction\n\nCaloric Restriction (CR): Participants follow a diet with 25% fewer calories than calculated at baseline over a period of 24 months', 'otherNumAtRisk': 143, 'deathsNumAtRisk': 143, 'otherNumAffected': 136, 'seriousNumAtRisk': 143, 'deathsNumAffected': 0, 'seriousNumAffected': 1}, {'id': 'EG001', 'title': 'Ad Libitum', 'description': 'Ad libitum energy intake\n\nControl: Participants continue their current diet for 24 months', 'otherNumAtRisk': 75, 'deathsNumAtRisk': 75, 'otherNumAffected': 72, 'seriousNumAtRisk': 75, 'deathsNumAffected': 0, 'seriousNumAffected': 7}], 'otherEvents': [{'term': 'sinus congestion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 43, 'numAffected': 23}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 17, 'numAffected': 8}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'dysmenorrhea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 78, 'numAffected': 30}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 31, 'numAffected': 11}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'dizziness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 48, 'numAffected': 9}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 14, 'numAffected': 10}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'diarrhea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 27, 'numAffected': 20}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 16, 'numAffected': 10}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'nasal congestion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 28, 'numAffected': 19}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 14, 'numAffected': 5}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'constipation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 44, 'numAffected': 18}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 11, 'numAffected': 5}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'toothache', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 21, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 12, 'numAffected': 5}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'muscle strain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 16, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 4, 'numAffected': 3}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'gastrointestinal virus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 16, 'numAffected': 13}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 5, 'numAffected': 5}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 20, 'numAffected': 12}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 10, 'numAffected': 5}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'rash', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 9, 'numAffected': 9}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'urinary tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 11, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 6, 'numAffected': 4}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'anemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 99, 'numAffected': 35}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 34, 'numAffected': 17}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'Excessive bone loss', 'notes': 'by BMD at lumbar spine, total hip and intertrochanter', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 3, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}], 'seriousEvents': [{'term': 'spontaneous miscarriage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'pneumothorax', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'leiomyoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'scoliosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'spinal osteoarthritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'intestinal abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'small intestinal obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}, {'term': 'atrial septal defect', 'stats': [{'groupId': 'EG000', 'numAtRisk': 143, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 75, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA (10.0)'}], 'frequencyThreshold': '0'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Change in Core Body Temperature, Baseline to 12 Months', 'denoms': [{'units': 'Participants', 'counts': [{'value': '143', 'groupId': 'OG000'}, {'value': '75', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Caloric Restriction (CR)', 'description': '25% caloric restriction\n\nCaloric Restriction (CR): Participants follow a diet with 25% fewer calories than calculated at baseline over a period of 24 months'}, {'id': 'OG001', 'title': 'Ad Libitum', 'description': 'Ad libitum energy intake\n\nControl: Participants continue their current diet for 24 months'}], 'classes': [{'categories': [{'measurements': [{'value': '-0.05', 'spread': '0.02', 'groupId': 'OG000'}, {'value': '-0.03', 'spread': '0.02', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '0.70', 'groupIds': ['OG000', 'OG001'], 'paramType': 'difference in mean change', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '0.02', 'ciLowerLimit': '-0.019', 'ciUpperLimit': '0.059', 'pValueComment': 'Type I error was controlled using a hierarchical gatekeeping strategy.', 'dispersionType': 'STANDARD_DEVIATION', 'dispersionValue': '0.02', 'groupDescription': 'All analysis under intention-to-treat. All observations were included The primary analytic was a repeated measures analysis. The dependent variable was the change from baseline 12 \\& 14mos., with treatment, time, and the treatment × time interaction as independent variables. Site, sex, BMI stratum, and the baseline value of the outcome were included as covariates. The predicted mean changes ± standard errors are the adjusted values from the contrasts of the multiple timepoints.', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'OTHER'}], 'paramType': 'MEAN', 'timeFrame': 'Baseline to 12 months', 'unitOfMeasure': 'degrees Celsius', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Change in Core Temperature, Baseline to 24 Months', 'denoms': [{'units': 'Participants', 'counts': [{'value': '143', 'groupId': 'OG000'}, {'value': '75', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Prescribed 25% Caloric Restriction', 'description': '2 years of prescribed 25% Caloric Restriction'}, {'id': 'OG001', 'title': 'Ad Libitum', 'description': 'Usual caloric intake'}], 'classes': [{'categories': [{'measurements': [{'value': '-0.05', 'spread': '0.02', 'groupId': 'OG000'}, {'value': '-0.02', 'spread': '0.02', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '0.84', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Mean Difference (Net)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '0.03', 'ciLowerLimit': '-0.0092', 'ciUpperLimit': '0.069', 'dispersionType': 'STANDARD_ERROR_OF_MEAN', 'dispersionValue': '0.02', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'OTHER'}], 'paramType': 'MEAN', 'timeFrame': 'Baseline to 24 months', 'unitOfMeasure': 'degrees Celsius', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Change in Resting Metabolic Rate (RMR) Corrected for Changes in Body Composition, Baseline to 12 Months', 'denoms': [{'units': 'Participants', 'counts': [{'value': '143', 'groupId': 'OG000'}, {'value': '75', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Caloric Restriction (CR)', 'description': '25% caloric restriction\n\nCaloric Restriction (CR): Participants follow a diet with 25% fewer calories than calculated at baseline over a period of 24 months'}, {'id': 'OG001', 'title': 'Ad Libitum', 'description': 'Ad libitum energy intake\n\nControl: Participants continue their current diet for 24 months'}], 'classes': [{'categories': [{'measurements': [{'value': '-83', 'spread': '10', 'groupId': 'OG000'}, {'value': '-1', 'spread': '13', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '<0.001', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Mean Difference (Net)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '-82', 'ciLowerLimit': '-103.8', 'ciUpperLimit': '-60.2', 'dispersionType': 'STANDARD_ERROR_OF_MEAN', 'dispersionValue': '11.12', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'OTHER'}], 'paramType': 'MEAN', 'timeFrame': 'Baseline, 12 months', 'unitOfMeasure': 'Kcal/day', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Change in Resting Metabolic Rate (RMR) Corrected for Changes in Body Composition', 'denoms': [{'units': 'Participants', 'counts': [{'value': '143', 'groupId': 'OG000'}, {'value': '75', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Caloric Restriction (CR)', 'description': '25% caloric restriction\n\nCaloric Restriction (CR): Participants follow a diet with 25% fewer calories than calculated at baseline over a period of 24 months'}, {'id': 'OG001', 'title': 'Ad Libitum', 'description': 'Ad libitum energy intake\n\nControl: Participants continue their current diet for 24 months'}], 'classes': [{'categories': [{'measurements': [{'value': '-71', 'spread': '12', 'groupId': 'OG000'}, {'value': '-7', 'spread': '16', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '<0.0001', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Mean Difference (Final Values)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '-64', 'ciLowerLimit': '-90.5', 'ciUpperLimit': '-37.5', 'dispersionType': 'STANDARD_DEVIATION', 'dispersionValue': '13.5', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'OTHER'}], 'paramType': 'MEAN', 'timeFrame': 'Baseline, 24 months', 'unitOfMeasure': 'Kcal/day', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Change in Tumor Necrosis Factor-α (TNF-α), Baseline to 12 Months', 'denoms': [{'units': 'Participants', 'counts': [{'value': '143', 'groupId': 'OG000'}, {'value': '75', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Caloric Restriction (CR)', 'description': '25% caloric restriction\n\nCaloric Restriction (CR): Participants follow a diet with 25% fewer calories than calculated at baseline over a period of 24 months'}, {'id': 'OG001', 'title': 'Ad Libitum', 'description': 'Ad libitum energy intake\n\nControl: Participants continue their current diet for 24 months'}], 'classes': [{'categories': [{'measurements': [{'value': '-0.30', 'spread': '0.09', 'groupId': 'OG000'}, {'value': '-0.34', 'spread': '0.12', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '0.82', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Mean Difference (Net)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '0.04', 'ciLowerLimit': '-0.16', 'ciUpperLimit': '0.23', 'dispersionType': 'STANDARD_ERROR_OF_MEAN', 'dispersionValue': '0.10', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'OTHER'}], 'paramType': 'MEAN', 'timeFrame': 'change baseline to 12 months', 'unitOfMeasure': 'pg/mL', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Change in Fat Mass', 'denoms': [{'units': 'Participants', 'counts': [{'value': '143', 'groupId': 'OG000'}, {'value': '75', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Prescribed 25% Caloric Restriction', 'description': '2 years of prescribed 25% Caloric Restriction'}, {'id': 'OG001', 'title': 'Ad Libitum', 'description': 'Usual caloric intake'}], 'classes': [{'categories': [{'measurements': [{'value': '-6.1', 'spread': '0.22', 'groupId': 'OG000'}, {'value': '-0.2', 'spread': '0.28', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '<0.001', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Mean Difference (Net)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '-5.9', 'ciLowerLimit': '-6.5', 'ciUpperLimit': '-5.3', 'dispersionType': 'STANDARD_ERROR_OF_MEAN', 'dispersionValue': '0.31', 'groupDescription': 'Difference in change in Fat Mass between prescribed 25% Caloric Restriction (CR) and Ad Libitum (AL) at 12 and 24 months as measured by dual X-ray absorptiometry (DXA) using the Hologic 4500A, Delphi W or Discovery A, by a standardized protocol according to a standardized protocol. Fat Mass (FM) and Fat Free Mass (FFM) were determined for the whole body.', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'OTHER'}], 'paramType': 'MEAN', 'timeFrame': 'change 0 to 24 months', 'description': 'Difference in change in Fat Mass between prescribed 25% Caloric Restriction (CR) and Ad Libitum (AL) at 12 and 24 months as measured by dual X-ray absorptiometry (DXA) using the Hologic 4500A, Delphi W or Discovery A, by a standardized protocol according to a standardized protocol. Fat Mass (FM) was determined for the whole body.', 'unitOfMeasure': 'kg', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Change in Fat Mass', 'denoms': [{'units': 'Participants', 'counts': [{'value': '143', 'groupId': 'OG000'}, {'value': '75', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Prescribed 25% Caloric Restriction', 'description': '2 years of prescribed 25% Caloric Restriction'}, {'id': 'OG001', 'title': 'Ad Libitum', 'description': 'Usual caloric intake'}], 'classes': [{'categories': [{'measurements': [{'value': '-6.1', 'spread': '0.22', 'groupId': 'OG000'}, {'value': '-0.3', 'spread': '0.28', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '<0.0001', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Mean Difference (Net)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '-5.9', 'ciLowerLimit': '-6.4', 'ciUpperLimit': '-5.3', 'dispersionType': 'STANDARD_ERROR_OF_MEAN', 'dispersionValue': '0.26', 'groupDescription': 'Comparison of change in FM in 2 groups over at 24 mos, controlling for site, sex, BMI group, and baseline FM. A repeated measures Mixed Model was employed for the analysis. For any outcome, Type I error was controlled using a hierarchical gatekeeping strategy testing, first, the GroupXTime interaction, and, if non-significant, the main effects of these two factors. Bonferroni corrections were employed for non-significant effects. All tests were at p\\<0.05', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'OTHER'}], 'paramType': 'MEAN', 'timeFrame': 'baseline, 12 months', 'description': 'Difference in change in Fat Mass between prescribed 25% Caloric Restriction (CR) and Ad Libitum (AL) at 12 and 24 months as measured by dual X-ray absorptiometry (DXA) using the Hologic 4500A, Delphi W or Discovery A, by a standardized protocol according to a standardized protocol. Fat Mass (FM) was determined for the whole body.', 'unitOfMeasure': 'Kg', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Caloric Restriction (CR)', 'description': '25% caloric restriction\n\nCaloric Restriction (CR): Participants follow a diet with 25% fewer calories than calculated at baseline over a period of 24 months'}, {'id': 'FG001', 'title': 'Ad Libitum', 'description': 'Ad libitum energy intake\n\nControl: Participants continue their current diet for 24 months'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '143'}, {'groupId': 'FG001', 'numSubjects': '75'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '117'}, {'groupId': 'FG001', 'numSubjects': '71'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '26'}, {'groupId': 'FG001', 'numSubjects': '4'}]}]}], 'preAssignmentDetails': '238 Participants were eligible, 18 participants withdrew prior to randomization, 220 participants were randomized to the study, and 2 participants withdrew prior to initiating the intervention.'}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '143', 'groupId': 'BG000'}, {'value': '75', 'groupId': 'BG001'}, {'value': '218', 'groupId': 'BG002'}]}], 'groups': [{'id': 'BG000', 'title': 'Caloric Restriction (CR)', 'description': '25% caloric restriction\n\nCaloric Restriction (CR): Participants follow a diet with 25% fewer calories than calculated at baseline over a period of 24 months'}, {'id': 'BG001', 'title': 'Ad Libitum', 'description': 'Ad libitum energy intake\n\nControl: Participants continue their current diet for 24 months'}, {'id': 'BG002', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Continuous', 'classes': [{'categories': [{'measurements': [{'value': '38.2', 'spread': '7.3', 'groupId': 'BG000'}, {'value': '38.1', 'spread': '6.9', 'groupId': 'BG001'}, {'value': '38.1', 'spread': '7.2', 'groupId': 'BG002'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'years', 'dispersionType': 'STANDARD_DEVIATION'}, {'title': 'Sex: Female, Male', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '99', 'groupId': 'BG000'}, {'value': '53', 'groupId': 'BG001'}, {'value': '152', 'groupId': 'BG002'}]}, {'title': 'Male', 'measurements': [{'value': '44', 'groupId': 'BG000'}, {'value': '22', 'groupId': 'BG001'}, {'value': '66', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race/Ethnicity, Customized', 'classes': [{'title': 'White', 'categories': [{'measurements': [{'value': '111', 'groupId': 'BG000'}, {'value': '57', 'groupId': 'BG001'}, {'value': '168', 'groupId': 'BG002'}]}]}, {'title': 'African-American', 'categories': [{'measurements': [{'value': '15', 'groupId': 'BG000'}, {'value': '11', 'groupId': 'BG001'}, {'value': '26', 'groupId': 'BG002'}]}]}, {'title': 'Other', 'categories': [{'measurements': [{'value': '17', 'groupId': 'BG000'}, {'value': '7', 'groupId': 'BG001'}, {'value': '24', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['OUTCOMES_ASSESSOR'], 'maskingDescription': 'all lab based assays were masked due to de-identified person and time interval measured. All physical measures were masked to intervention group status.'}, 'primaryPurpose': 'PREVENTION', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 238}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2007-05'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2022-03', 'completionDateStruct': {'date': '2012-11', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2022-03-14', 'studyFirstSubmitDate': '2007-01-24', 'resultsFirstSubmitDate': '2018-04-25', 'studyFirstSubmitQcDate': '2007-01-25', 'lastUpdatePostDateStruct': {'date': '2022-03-16', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2018-12-04', 'studyFirstPostDateStruct': {'date': '2007-01-26', 'type': 'ESTIMATED'}, 'resultsFirstPostDateStruct': {'date': '2018-12-06', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2012-11', 'type': 'ACTUAL'}}, 'outcomesModule': {'otherOutcomes': [{'measure': 'Change in Fat Mass', 'timeFrame': 'change 0 to 24 months', 'description': 'Difference in change in Fat Mass between prescribed 25% Caloric Restriction (CR) and Ad Libitum (AL) at 12 and 24 months as measured by dual X-ray absorptiometry (DXA) using the Hologic 4500A, Delphi W or Discovery A, by a standardized protocol according to a standardized protocol. Fat Mass (FM) was determined for the whole body.'}, {'measure': 'Change in Fat Mass', 'timeFrame': 'baseline, 12 months', 'description': 'Difference in change in Fat Mass between prescribed 25% Caloric Restriction (CR) and Ad Libitum (AL) at 12 and 24 months as measured by dual X-ray absorptiometry (DXA) using the Hologic 4500A, Delphi W or Discovery A, by a standardized protocol according to a standardized protocol. Fat Mass (FM) was determined for the whole body.'}], 'primaryOutcomes': [{'measure': 'Change in Core Body Temperature, Baseline to 12 Months', 'timeFrame': 'Baseline to 12 months'}, {'measure': 'Change in Core Temperature, Baseline to 24 Months', 'timeFrame': 'Baseline to 24 months'}, {'measure': 'Change in Resting Metabolic Rate (RMR) Corrected for Changes in Body Composition, Baseline to 12 Months', 'timeFrame': 'Baseline, 12 months'}, {'measure': 'Change in Resting Metabolic Rate (RMR) Corrected for Changes in Body Composition', 'timeFrame': 'Baseline, 24 months'}], 'secondaryOutcomes': [{'measure': 'Change in Tumor Necrosis Factor-α (TNF-α), Baseline to 12 Months', 'timeFrame': 'change baseline to 12 months'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'keywords': ['dietary restriction', 'disease /disorder prevention /control', 'nutrition of aging', 'bioenergetics', 'cardiovascular function', 'disease /disorder proneness /risk', 'insulin sensitivity / resistance'], 'conditions': ['Aging']}, 'referencesModule': {'references': [{'pmid': '26187233', 'type': 'RESULT', 'citation': 'Ravussin E, Redman LM, Rochon J, Das SK, Fontana L, Kraus WE, Romashkan S, Williamson DA, Meydani SN, Villareal DT, Smith SR, Stein RI, Scott TM, Stewart TM, Saltzman E, Klein S, Bhapkar M, Martin CK, Gilhooly CH, Holloszy JO, Hadley EC, Roberts SB; CALERIE Study Group. A 2-Year Randomized Controlled Trial of Human Caloric Restriction: Feasibility and Effects on Predictors of Health Span and Longevity. J Gerontol A Biol Sci Med Sci. 2015 Sep;70(9):1097-104. doi: 10.1093/gerona/glv057. Epub 2015 Jul 17.'}, {'pmid': '20923909', 'type': 'RESULT', 'citation': 'Rochon J, Bales CW, Ravussin E, Redman LM, Holloszy JO, Racette SB, Roberts SB, Das SK, Romashkan S, Galan KM, Hadley EC, Kraus WE; CALERIE Study Group. Design and conduct of the CALERIE study: comprehensive assessment of the long-term effects of reducing intake of energy. J Gerontol A Biol Sci Med Sci. 2011 Jan;66(1):97-108. doi: 10.1093/gerona/glq168. Epub 2010 Oct 5.'}, {'pmid': '29045325', 'type': 'RESULT', 'citation': 'Racette SB, Rochon J, Uhrich ML, Villareal DT, DAS SK, Fontana L, Bhapkar M, Martin CK, Redman LM, Fuss PJ, Roberts SB, Kraus WE. Effects of Two Years of Calorie Restriction on Aerobic Capacity and Muscle Strength. Med Sci Sports Exerc. 2017 Nov;49(11):2240-2249. doi: 10.1249/MSS.0000000000001353.'}, {'pmid': '28531269', 'type': 'RESULT', 'citation': 'Belsky DW, Huffman KM, Pieper CF, Shalev I, Kraus WE. Change in the Rate of Biological Aging in Response to Caloric Restriction: CALERIE Biobank Analysis. J Gerontol A Biol Sci Med Sci. 2017 Dec 12;73(1):4-10. doi: 10.1093/gerona/glx096.'}, {'pmid': '27136347', 'type': 'RESULT', 'citation': 'Martin CK, Bhapkar M, Pittas AG, Pieper CF, Das SK, Williamson DA, Scott T, Redman LM, Stein R, Gilhooly CH, Stewart T, Robinson L, Roberts SB; Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) Phase 2 Study Group. Effect of Calorie Restriction on Mood, Quality of Life, Sleep, and Sexual Function in Healthy Nonobese Adults: The CALERIE 2 Randomized Clinical Trial. JAMA Intern Med. 2016 Jun 1;176(6):743-52. doi: 10.1001/jamainternmed.2016.1189.'}, {'pmid': '39672986', 'type': 'DERIVED', 'citation': 'Ryan CP, Corcoran DL, Banskota N, Eckstein Indik C, Floratos A, Friedman R, Kobor MS, Kraus VB, Kraus WE, MacIsaac JL, Orenduff MC, Pieper CF, White JP, Ferrucci L, Horvath S, Huffman KM, Belsky DW. The CALERIE Genomic Data Resource. Nat Aging. 2025 Feb;5(2):320-331. doi: 10.1038/s43587-024-00775-0. Epub 2024 Dec 13.'}, {'pmid': '39270937', 'type': 'DERIVED', 'citation': 'Glasbrenner C, Hochsmann C, Pieper CF, Wasserfurth P, Dorling JL, Martin CK, Redman LM, Koehler K. Prediction of individual weight loss using supervised learning: findings from the CALERIETM 2 study. Am J Clin Nutr. 2024 Nov;120(5):1233-1244. doi: 10.1016/j.ajcnut.2024.09.003. Epub 2024 Sep 11.'}, {'pmid': '37781916', 'type': 'DERIVED', 'citation': 'Ryu S, Spadaro O, Sidorov S, Lee AH, Caprio S, Morrison C, Smith SR, Ravussin E, Shchukina I, Artyomov MN, Youm YH, Dixit VD. Reduction of SPARC protects mice against NLRP3 inflammasome activation and obesity. J Clin Invest. 2023 Oct 2;133(19):e169173. doi: 10.1172/JCI169173.'}, {'pmid': '36805108', 'type': 'DERIVED', 'citation': 'Silver RE, Roberts SB, Kramer AF, Chui KKH, Das SK. No Effect of Calorie Restriction or Dietary Patterns on Spatial Working Memory During a 2-Year Intervention: A Secondary Analysis of the CALERIE Trial. J Nutr. 2023 Mar;153(3):733-740. doi: 10.1016/j.tjnut.2023.01.019. Epub 2023 Jan 14.'}, {'pmid': '32803412', 'type': 'DERIVED', 'citation': 'Dorling JL, Ravussin E, Redman LM, Bhapkar M, Huffman KM, Racette SB, Das SK, Apolzan JW, Kraus WE, Hochsmann C, Martin CK; CALERIE Phase 2 Study Group. Effect of 2 years of calorie restriction on liver biomarkers: results from the CALERIE phase 2 randomized controlled trial. Eur J Nutr. 2021 Apr;60(3):1633-1643. doi: 10.1007/s00394-020-02361-7. Epub 2020 Aug 14.'}, {'pmid': '31552422', 'type': 'DERIVED', 'citation': 'Thomas DM, Clark N, Turner D, Siu C, Halliday TM, Hannon BA, Kahathuduwa CN, Kroeger CM, Zoh R, Allison DB. Best (but oft-forgotten) practices: identifying and accounting for regression to the mean in nutrition and obesity research. Am J Clin Nutr. 2020 Feb 1;111(2):256-265. doi: 10.1093/ajcn/nqz196.'}, {'pmid': '31398376', 'type': 'DERIVED', 'citation': 'Dorling JL, Bhapkar M, Das SK, Racette SB, Apolzan JW, Fearnbach SN, Redman LM, Myers CA, Stewart TM, Martin CK; CALERIE Study Group. Change in self-efficacy, eating behaviors and food cravings during two years of calorie restriction in humans without obesity. Appetite. 2019 Dec 1;143:104397. doi: 10.1016/j.appet.2019.104397. Epub 2019 Aug 6.'}, {'pmid': '31303390', 'type': 'DERIVED', 'citation': 'Kraus WE, Bhapkar M, Huffman KM, Pieper CF, Krupa Das S, Redman LM, Villareal DT, Rochon J, Roberts SB, Ravussin E, Holloszy JO, Fontana L; CALERIE Investigators. 2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. Lancet Diabetes Endocrinol. 2019 Sep;7(9):673-683. doi: 10.1016/S2213-8587(19)30151-2. Epub 2019 Jul 11.'}, {'pmid': '30998529', 'type': 'DERIVED', 'citation': 'Broskey NT, Marlatt KL, Most J, Erickson ML, Irving BA, Redman LM. The Panacea of Human Aging: Calorie Restriction Versus Exercise. Exerc Sport Sci Rev. 2019 Jul;47(3):169-175. doi: 10.1249/JES.0000000000000193.'}, {'pmid': '29635495', 'type': 'DERIVED', 'citation': 'Guo J, Brager DC, Hall KD. Simulating long-term human weight-loss dynamics in response to calorie restriction. Am J Clin Nutr. 2018 Apr 1;107(4):558-565. doi: 10.1093/ajcn/nqx080.'}, {'pmid': '29576535', 'type': 'DERIVED', 'citation': "Redman LM, Smith SR, Burton JH, Martin CK, Il'yasova D, Ravussin E. Metabolic Slowing and Reduced Oxidative Damage with Sustained Caloric Restriction Support the Rate of Living and Oxidative Damage Theories of Aging. Cell Metab. 2018 Apr 3;27(4):805-815.e4. doi: 10.1016/j.cmet.2018.02.019. Epub 2018 Mar 22."}, {'pmid': '28228420', 'type': 'DERIVED', 'citation': 'Das SK, Roberts SB, Bhapkar MV, Villareal DT, Fontana L, Martin CK, Racette SB, Fuss PJ, Kraus WE, Wong WW, Saltzman E, Pieper CF, Fielding RA, Schwartz AV, Ravussin E, Redman LM; CALERIE-2 Study Group. Body-composition changes in the Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE)-2 study: a 2-y randomized controlled trial of calorie restriction in nonobese humans. Am J Clin Nutr. 2017 Apr;105(4):913-927. doi: 10.3945/ajcn.116.137232. Epub 2017 Feb 22.'}, {'pmid': '27900372', 'type': 'DERIVED', 'citation': 'Rochon J, Bhapkar M, Pieper CF, Kraus WE. Application of the Marginal Structural Model to Account for Suboptimal Adherence in a Randomized Controlled Trial. Contemp Clin Trials Commun. 2016 Dec 15;4:222-228. doi: 10.1016/j.conctc.2016.10.005. Epub 2016 Nov 3.'}, {'pmid': '27778643', 'type': 'DERIVED', 'citation': 'Sparks LM, Redman LM, Conley KE, Harper ME, Yi F, Hodges A, Eroshkin A, Costford SR, Gabriel ME, Shook C, Cornnell HH, Ravussin E, Smith SR. Effects of 12 Months of Caloric Restriction on Muscle Mitochondrial Function in Healthy Individuals. J Clin Endocrinol Metab. 2017 Jan 1;102(1):111-121. doi: 10.1210/jc.2016-3211.'}, {'pmid': '27410480', 'type': 'DERIVED', 'citation': 'Meydani SN, Das SK, Pieper CF, Lewis MR, Klein S, Dixit VD, Gupta AK, Villareal DT, Bhapkar M, Huang M, Fuss PJ, Roberts SB, Holloszy JO, Fontana L. Long-term moderate calorie restriction inhibits inflammation without impairing cell-mediated immunity: a randomized controlled trial in non-obese humans. Aging (Albany NY). 2016 Jul;8(7):1416-31. doi: 10.18632/aging.100994.'}, {'pmid': '26040640', 'type': 'DERIVED', 'citation': 'Sanghvi A, Redman LM, Martin CK, Ravussin E, Hall KD. Validation of an inexpensive and accurate mathematical method to measure long-term changes in free-living energy intake. Am J Clin Nutr. 2015 Aug;102(2):353-8. doi: 10.3945/ajcn.115.111070. Epub 2015 Jun 3.'}, {'pmid': '24523488', 'type': 'DERIVED', 'citation': 'Wong WW, Roberts SB, Racette SB, Das SK, Redman LM, Rochon J, Bhapkar MV, Clarke LL, Kraus WE. The doubly labeled water method produces highly reproducible longitudinal results in nutrition studies. J Nutr. 2014 May;144(5):777-83. doi: 10.3945/jn.113.187823. Epub 2014 Feb 12.'}, {'pmid': '24257721', 'type': 'DERIVED', 'citation': 'Redman LM, Kraus WE, Bhapkar M, Das SK, Racette SB, Martin CK, Fontana L, Wong WW, Roberts SB, Ravussin E; CALERIE Study Group. Energy requirements in nonobese men and women: results from CALERIE. Am J Clin Nutr. 2014 Jan;99(1):71-8. doi: 10.3945/ajcn.113.065631. Epub 2013 Nov 20.'}, {'pmid': '22523532', 'type': 'DERIVED', 'citation': 'Huffman KM, Redman LM, Landerman LR, Pieper CF, Stevens RD, Muehlbauer MJ, Wenner BR, Bain JR, Kraus VB, Newgard CB, Ravussin E, Kraus WE. Caloric restriction alters the metabolic response to a mixed-meal: results from a randomized, controlled trial. PLoS One. 2012;7(4):e28190. doi: 10.1371/journal.pone.0028190. Epub 2012 Apr 16.'}], 'seeAlsoLinks': [{'url': 'https://calerie.duke.edu/', 'label': 'CALERIE website'}]}, 'descriptionModule': {'briefSummary': 'The purpose of this study is to test the hypothesis that two years of sustained 25% caloric restriction (CR) in men age 21-50 (inclusive) and women age 21-47 (inclusive) will slow aging and protect against age-related disease processes.', 'detailedDescription': 'The overall aim of CALERIE Phase 2 is to test the hypothesis that two years of sustained caloric restriction (CR), involving a reduction in energy intake to 75% of baseline (25% CR), in healthy, non-obese men aged 21-50 (inclusive) and women aged 21-47 (inclusive), will result in the same adaptive changes that were observed in a wide variety of animal studies. Particular emphasis is on the adaptive responses thought to be involved in slowing the aging process and protecting against age-related disease processes. Primary outcomes include core body temperature and resting metabolic rate. Secondary outcomes include risk factors for cardiovascular disease, inflammatory markers, immune function, psychological and physical function; oxidative changes in lipids, proteins, and DNA; and, risk factors for age-related conditions such as diabetes and body composition. An important secondary aim is to identify potential adverse effects of CR in humans.\n\nThe study will be conducted as a multi-center, parallel-group, randomized, controlled trial (RCT). A sample of 200 participants will be enrolled, and assigned to either the CR intervention or a control group. Control participants will be advised to simply continue their current diets. Participants in both treatment arms will be followed over a period of 24 months. A comprehensive set of evaluations will be performed prior to initiating the intervention, with follow-up evaluations at 1, 3, 6, 9, 12, 18 and 24 months afterwards.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '50 Years', 'minimumAge': '21 Years', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Age must be between 21-50 (inclusive) for men and 21-47 (inclusive) for women\n* Body mass index (BMI) must be greater than or equal to 22 and less than 28\n* Female participants must use acceptable forms of contraception (barrier method, oral contraceptive, intra-uterine device, or similar) and be willing to continue using such a method while enrolled in the study\n\nExclusion Criteria:\n\n* History or clinical manifestation of cardiovascular disease or an elevated blood pressure (greater than 140/90 mm Hg)\n* Abnormal resting ECG\n* History or clinical manifestation of diabetes\n* History or clinical manifestation of cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)\n* History of anaphylaxis, severe allergies, or asthma\n* History or clinical manifestation of any other significant metabolic, hematologic, pulmonary, cardiovascular, gastrointestinal, neurologic, immune, hepatic, renal, urologic disorders, or cancer that, in opinion of the investigator, would make the candidate ineligible for the study\n* History of stomach or intestinal surgery (except appendectomy) or major abdominal, thoracic or non-peripheral vascular surgery within one year prior to the randomization date\n* Any disease or condition that seriously affects body weight and/or body composition\n* Potassium level above the upper limit of normal at the screening visit confirmed by a test repeated within two weeks\n* Hemoglobin, hematocrit, RBC, or iron level below the lower limit of normal at the screening visit confirmed by a test repeated within two weeks\n* Evidence of active liver disease or ALT levels above 1.5 times the upper limit of normal\n* Practice a vegan dietary lifestyle\n* History or clinical manifestation of any eating disorder\n* Any history of pharmacologic treatment for a psychiatric disorder within one year prior to the randomization date or a history of more than one episode of a pharmacologic treatment for a psychiatric disorder within lifetime\n* History of drug or alcohol abuse (up to 14 drinks a week are allowed) within the past two years\n* BDI (Beck Depression Inventory) score of 20 or higher at screening or baseline\n* Treatment with steroids for more than a month within five years prior to the randomization date, or short-term (less than a month) treatment with steroids within six months prior to the randomization date\n* Regular use of other medications, except contraceptives\n* Participated in the CALERIE Phase 1 studies\n* Lost or gained 3 kg or more over the past six months\n* A volunteer must be either a never-smoker of tobacco products or an ex-smoker who quit completely at least 12 months prior to the screening visit\n* Donated blood within 30 days prior to the randomization date\n* Concurrent participation in any other interventional study\n* Breast-feeding or pregnant women or women intending to become pregnant before the scheduled end of the intervention\n* Engaged in a regular program of physical fitness involving some kind of heavy physical activity (e.g., jogging, running or riding fast on a bicycle for 30 minutes or more) five or more times per week over the past year\n* Unwilling to be assigned at random to the CR or control intervention\n* Unwilling or unable to adhere to the rigors of the CR intervention over the entire two-year intervention period\n* Unable or unwilling to discontinue dietary supplements or adhere to the alcohol consumption restrictions during the study\n* Unwilling or unable to adhere to the rigors of the data collection and clinical evaluation schedule over the entire two-year period follow-up period'}, 'identificationModule': {'nctId': 'NCT00427193', 'briefTitle': 'CALERIE: Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy', 'organization': {'class': 'OTHER', 'fullName': 'Duke University'}, 'officialTitle': 'Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy (CALERIE)', 'orgStudyIdInfo': {'id': 'Pro00016876'}, 'secondaryIdInfos': [{'id': 'PBRC U01-AG0204878'}, {'id': 'Tufts U01-AG020480'}, {'id': 'WashU U01-AG020487'}, {'id': 'DCRI/Duke U01-AG022132'}, {'id': 'AG0078'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Caloric Restriction (CR)', 'description': '25% caloric restriction', 'interventionNames': ['Behavioral: Caloric Restriction (CR)']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Control, Ad libitum (AL)', 'description': 'Ad libitum energy intake', 'interventionNames': ['Behavioral: Control']}], 'interventions': [{'name': 'Caloric Restriction (CR)', 'type': 'BEHAVIORAL', 'description': 'Participants follow a diet with 25% fewer calories than calculated at baseline over a period of 24 months', 'armGroupLabels': ['Caloric Restriction (CR)']}, {'name': 'Control', 'type': 'BEHAVIORAL', 'description': 'Participants continue their current diet for 24 months', 'armGroupLabels': ['Control, Ad libitum (AL)']}]}, 'contactsLocationsModule': {'locations': [{'zip': '70808', 'city': 'Baton Rouge', 'state': 'Louisiana', 'country': 'United States', 'facility': 'Pennington Biomedical Research Center', 'geoPoint': {'lat': 30.44332, 'lon': -91.18747}}, {'zip': '02111', 'city': 'Boston', 'state': 'Massachusetts', 'country': 'United States', 'facility': 'Jean Mayer Human Nutrition Research Center on Aging at Tufts University', 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'zip': '63110', 'city': 'St Louis', 'state': 'Missouri', 'country': 'United States', 'facility': 'Washington University School of Medicine', 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}], 'overallOfficials': [{'name': 'William Kraus, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Duke Clinical Research Institute'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Duke University', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}